Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
Canaccord Genuity Reiterates a 'Buy' on TransCanada (TRP); Files For 2011 Mainline Interim Tolls;
-
Canaccord Genuity reiterates a 'Buy' rating on Nuance Communications (NUAN); Analyst Day Outlines Prospects for Long-Term Growth
-
Canaccord Genuity Starts Allied Nevada Gold (ANV) at Buy; "Good Odds" in Nevada at Hycroft
-
Canaccord Genuity Reiterates a 'Buy' on Orexigen Therapeutics (OREX); Provides More Clarity on Contrave's Path Forward; Stock Has Room
-
Canaccord Genuity Maintains a 'Buy' on Telvent Git (TLVT); Helping Farmers Find (and Keep) a Fortune
-
Canaccord Genuity Reiterates 'Buy' on Ceragon Networks (CRNT), PT Raised to $15
-
Canaccord Genuity Reiterates a 'Buy' on Anaren (ANEN); Increasing Confidence in 2011 Growth Drivers
-
Canaccord Genuity maintains a 'Buy' on Gastar Exploration Limited (GST); Completes Offering to Fund Accretive Acquisition
-
Canaccord Genuity Morning Coffee on Texas Instruments (TXN): Nice Handle
-
Canaccord Genuity Morning Coffee on TASER International (TASR): Zap!
-
Canaccord Genuity Morning Coffee on Netflix (NFLX): Home For The Holidays...And Then Some
-
Canaccord Genuity Morning Coffee on ArcelorMittal (MT): Stainless
-
Canaccord Genuity Morning Coffee on Mastercard (MA): What?!? I Never Spent $1,000 at 7-11!
-
Notable Analyst Rating Changes 12/08: VVUS, FWLT, DOLE, ISIL Upgraded; NFLX, PCX, TXN, WTI Downgraded
-
Canaccord Genuity Reiterates a 'Buy' on Orexigen Therapeutics (OREX); OREX Shoots and Scores; FDA Panel Gives Contrave a Big Fat Yes
-
Canaccord Genuity Maintains a 'Buy' on KMG Chemicals (KMGB); Oct. Quarter Earnings Preview
-
Canaccord Genuity Maintains a 'Buy/Best Idea' on NCI Building Systems (NCS); Positioned for Recovery
-
Canaccord Genuity Reiterates a 'Hold' on Texas Instruments (TXN); Narrows Guidance To Midpoint, We See Limited Upside To 2011
-
Canaccord Genuity Upgrades Intersil (ISIL) to Buy, Price Target $18
-
After-Hours Movers 12/07: VVUS, MIND, AVAV, COO Higher; MW, PPO, NFLX, STWD, MNTA, TXN Lower
-
What Apple (AAPL) Will Do in 2011
-
Insulet Corporation (PODD) Completes Sale of 3 Million Common Shares
-
Nexen (NXY) Shares Move Slightly Lower Following Mid-Day Downgrade at Canaccord Genuity
-
Canaccord Genuity Reiterates a 'Buy' on Casella Waste Systems (CWST); Seizing The Trading Opportunity
-
Canaccord Genuity Maintains a 'Buy' on Cytokinetics (CYTK); Think CK357 Phase 1/2 ALS Efficacy Data Will Be Next Catalyst
-
Canaccord Genuity Starts Atmel (ATML) at Buy; Increasing Estimates on Strong Near-Term Tablet Ramp
-
Canaccord Genuity Maintains a 'Buy' on Onyx Pharmaceuticals (ONXX); Carfilzomib Show Fron-Line Promise
-
Canaccord Genuity Morning Coffee on Orexigen (OREX): Weighing in...
-
Canaccord Genuity Morning Coffee on Mobile Phones: Tally-ho!
-
Canaccord Genuity Morning Coffee on Mitel Networks (MITL): YourTel
-
Canaccord Genuity Morning Coffee on Monster Worldwide (MWW): Rawr
-
Canaccord Genuity Morning Coffee on Gentex (GNTX): Vroom!
-
Canaccord Genuity Morning Coffee on VeriFone Systems (PAY): Small Fry
-
Canaccord Genuity Upgrades Jacobs Engineering (JEC) to Buy, Raises Price Target to $50
-
Canaccord Genuity Morning Coffee on Las Vegas Sands (LVS): No Chicken Dinner
-
Canaccord Genuity Morning Coffee on Unemployment Rate: Want a Job?
-
Daily State of the Markets 12/06: Always Looking For Answers
-
Canaccord Genuity reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Fencing Off m-enox: MNTA Files Infringement Suit Against Teva
-
Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); Singular focus on XL184 For Prostate Cancer
-
Canaccord Genuity reiterates a 'Buy' rating on Schnitzer Steel (SCHN); Acquisitions Expand Footprint, Industry Fundamentals Remain Positive
-
Canaccord Genuity Maintains a 'Buy' on Kadant Inc. (KAI); Positive industry Data Points Increase Our Confidence in Q4 Estimates
-
Canaccord Genuity Reiterates a 'Buy' Rating on Medifast (MED); Inexpensive Growth to Stuff in Your Stockings
-
Canaccord Genuity Downgrades CIBC (CM) to Hold
-
Canaccord Genuity Maintains a 'Hold' on Mitel (MITL); SME Challenges Persist
-
Canaccord Genuity Reiterates a 'Buy' on RPC Inc. (RES); Continued Strength in Market Pushes Our Estimates Higher
-
Canaccord Genuity Reiterates a 'Buy' on Precision Drilling (PDS); Looking Solid Into Winter
-
Canaccord Genuity Morning Coffee on SPDR Homebuilders ETF (XHB): Home On The Range
-
Canaccord Genuity Morning Coffee on Tesla Motors (TSLA): A Few Screws Short
-
Canaccord Genuity Morning Coffee on Qualcomm (QCOM): That’s Quality
-
Canaccord Genuity Morning Coffee on Magnum Hunter (MHR): Miami Vice Stories
